As the opioid addition crisis becomes increasingly worse across the U.S. over the past several years, federal policy changes are being implemented to shift patient evaluations toward a virtual format. A focus on buprenorphine, an effective treatment for opioid disorder, was another major aspect of these policy changes, as it is easy to prescribe in a telemedicine setting. Researchers at the University of Washington are exploring whether these changes in policy are affecting the disproportionate access to buprenorphine experienced by…
UW study assesses disproportionate access to opioid addiction treatment









